Role of Lashunadi ghrita in the management of Absence of menses

Study the efficacy of Lashunadi ghrita in the management of Nastartava Single group Clinical

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020662

Enrollment

Registered

2019-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N911- Secondary amenorrhea

Interventions

Intervention1: LASHUNADI GHRITA: Lashunadi ghrita 6gm Orally twice a day with luke warm water before meal for a period of 3 months Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Women of age group between 18 to 35 years complaining of absence of menstruation for last 3 or more month consecutively will be selected patient should be interested and give their consent for the study work

Exclusion criteria

Exclusion criteria: patient with primary Aamenorrhhoea Patient with gross structural abnormalities of genital tract patient with physiological amenorrhoea like puberty lactation pregnancy menopause Systemic illness Hypertension Diabetes Mellitus cardiac disease etc

Design outcomes

Primary

Measure	Time frame
Occurrence of MenstruationTimepoint: 6months	—

Secondary

Measure	Time frame
further regulation of menstrual cyclesTimepoint: 6 months	—

Countries

India

Contacts

Public ContactNida Qamar

All India Institute Of Ayurveda

sujatadkadam@gmail.com9890305370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026